Anzeige
Mehr »
Sonntag, 01.03.2026 - Börsentäglich über 12.000 News
Erste Psilocybin-Behandlungen laufen - warum steht Optimi noch bei Pennystock-Level?!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von MassDevice

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
FrAbbott earns FDA green light for next-gen CardioMEMS pulmonary artery pressure reader
FrThink Surgical announces first TMINI robot cases with Stryker knee implant
FrSynergy Spine gets FDA nod for cervical disc
FrBlueWind Medical data backs Revi tibial neuromod for UUI
FrBoston Scientific enters into multiple credit facilities totaling $11B
FrDexcom adds Google exec to its board
FrSolventum exceeds earnings estimates in first year as solo company
DoGE HealthCare inks 10-year Care Alliance with UCSF Health
DoHighridge Medical begins limited rollout of activL lumbar disc
DoEdwards advances global heart health initiatives
DoBlue Arbor adds $5M in Ottobock partnership to advance neuromuscular interface
DoJohnson & Johnson Medtech launches new CereGlide aspiration catheters in US
DoMedtronic reports positive findings for Altaviva tibial neuromod for urinary incontinence
DoEnovis posts 24% sales growth in mixed Q4
MiTrinity Biotech raises $25M as it looks to advance CGM+ system
MiBoston Scientific promotes new president of Vascular Therapies from within
MiFDA warns on heart pump purge cassette issue from J&J's Abiomed
MiGE HealthCare debuts next-generation LOGIQ ultrasound systems
MiMedtronic launches MiniMed Go smart MDI system with Simplera sensor in Europe
MiMedline reports growth in Q4 despite earnings shortcomings
MiAbbott offers $20B in notes to finance Exact Sciences acquisition
MiQuantum Surgical acquires Neuwave Medical from J&J to form new surgical robotic venture
MiLivaNova reports 12% sales growth in Street-beating Q4
MiGlobus Medical surpasses market expectations, driven by acquisitions
MiNeurent Medical reports positive findings for Neuromark chronic rhinitis device